Actively Recruiting
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Led by M.D. Anderson Cancer Center · Updated on 2026-04-21
300
Participants Needed
1
Research Sites
575 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
CONDITIONS
Official Title
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
- Age �38; 18 years
- Plan to obtain the majority of treatment at MD Anderson Cancer Center including surgery and radiotherapy
- Ability to understand and willingness to sign written informed consent
You will not qualify if you...
- History of previous solid or liquid malignancies, other than skin cancers treated with local therapy
- Existing neurocognitive impairment not caused by sinonasal or nasopharyngeal cancers or their treatment
- Previous treatment for sinonasal or nasopharyngeal carcinomas, except biopsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Shirley Su, MBBS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here